John Harling

John Harling

Company: GlaxoSmithKline

Job title: Senior Scientific Director of Medicinal Chemistry

Bio:

I conducted both my B.Sc and Ph.D at Imperial followed by two years as a Postdoctoral Researcher at the University of Texas at Austin. Joined GlaxoSmithKline (then SmithKlineBeecham) as a Medicinal Chemist in 1991. During my >25 years at GSK I have worked in programs spanning Neurosciences, Cardiovascular and Respiratory therapeutic areas. In 2007 I was appointed as a Medicinal Chemistry Department Head in the Respiratory therapeutic area. In 2012 I became involved in the initiation of an exploratory effort to assess the potential of a new protein degradation technology through collaboration with Professor Craig Crews at Yale. My current position is Senior Scientific Director within Medicinal Chemistry at GSK where I have a remit to develop protein degradation capability at GSK.

Seminars:

Discussion/Q&A 10:15 am

Read more

day: Day Two

Discussion/Q&A 12:10 pm

Read more

day: Day One

Discussion/Q&A 5:10 pm

Read more

day: Day One

Chair’s Opening Remarks 8:55 am

Read more

day: Day Two

Chair’s Closing Remarks & End of Day One 5:30 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.